Mutation Analysis in Cultured Cells of Transgenic Rodents.

Area of Science:

• Toxicology
• Genetics
• Cell Biology

Background:

• Ethical considerations drive a shift from in vivo animal studies to in vitro mutation research.
• Transgenic rodent cell cultures provide alternatives for mutagenicity testing.
• The Big Blue® mouse model and λ Select cII assay are established tools for carcinogen evaluation.

Purpose of the Study:

• To review techniques for using the Big Blue® mouse embryonic fibroblast model and λ Select cII assay for mutagenicity testing.
• To detail methods for in vitro cell treatment, mutation detection, and data analysis.
• To highlight applications and discuss the advantages and limitations of this in vitro approach.

Main Methods:

• Preparation and culturing of Big Blue® mouse embryonic fibroblasts.
• In vitro exposure to chemical or physical agents.
• Determination of cII mutant frequency using the λ Select cII assay.
• Mutation spectrum analysis via DNA sequencing.

Main Results:

• The Big Blue® mouse cell culture model and λ Select cII assay are effective for assessing mutagenicity of various carcinogens.
• Established protocols exist for cell culture, agent treatment, and mutation frequency determination.
• Representative studies demonstrate the utility of this system for diverse mutagenicity testing.

Conclusions:

• The Big Blue® mouse cell culture system combined with the λ Select cII assay is a valuable in vitro tool for mutagenicity testing.
• This approach offers advantages over traditional in vivo methods for evaluating carcinogens.
• Further research can explore auxiliary methods to enhance the application of this model.